Llwytho...
MDM2 antagonist nutlin‐3a sensitizes tumors to V‐ATPase inhibition
Treating cancer is one of the big challenges of this century and it has become evident that single chemotherapeutic treatment is rarely effective. As tumors often carry multiple mutations using combination therapy which addresses different targets seems therefore more beneficial. One of the most fre...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Oncol |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423188/ https://ncbi.nlm.nih.gov/pubmed/27157929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2016.04.005 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|